June 8, 2023

The American College of Radiology® (ACR®) and Society of Breast Imaging (SBI) submitted joint comments in response to the United States Preventive Services Task Force (USPSTF) draft recommendations for breast cancer screening, acknowledging that the proposed move toward screening average risk women beginning at age 40 is a step in the right direction, while objecting to other aspects of the Task Force’s recommendations.

The highly detailed and scientifically robust comments raise serious concerns with the proposed recommendation for biennial rather than annual screening, given the Task Force’s acknowledgement that annual mammography screening for women 40 and older saves the most lives and results in the greatest number of life years. ACR and SBI also expressed deep disappointment that the proposed USPSTF recommendation continues to perpetuate confusion surrounding when to cease mammographic screening by proposing a recommendation for screening mammography in women 75 and older. The associations’ position is that screening mammography should continue as long as a woman is in good health with reasonable life expectancy.

The comments provide an expository review of available science and rebut the Task Force’s approach and conclusions on multiple issues while respectfully urging that it reconsider the evidence as detailed in the ACR/SBI comments and adopt final recommendations assigning a B grade for annual mammographic screening for all women ages 40 and older who are at average risk for breast cancer.

USPSTF will review submitted comments prior to issuing final recommendations at a later date. For more information, contact Gloria Romanelli, ACR Senior Director, Legislative and Regulatory Relations, Legal Counsel Quality and Safety.


Related ACR News

  • President Biden Issues Executive Order to Advance Women's Health Research and Innovation

    The White House released an Executive Order (EO) to Advance Women’s Health Research and Innovation March 18, as part of the Biden Administration’s White House Initiative on Women’s Health Research. The EO directs a multitude of federal agencies to develop and strengthen research and data standards on women’s health across all relevant research and funding opportunities. These actions build on the recent announcement of the Advanced Research Projects Agency for Health Sprint for Women’s Health, which committed $100 million toward transformative research and development in women’s health.

    Read more
  • Partner With ACR in ARPA-H $100 Million Funding Opportunity to Improve Women's Health Outcomes

    The Advanced Research Projects Agency for Health (ARPA-H) recently announced the Sprint for Women’s Health, a funding opportunity for researchers to discover unconventional approaches and innovative ways to push high-impact biomedical research forward to improve women’s health outcomes. ARPA-H intends the effort to fundamentally change the trajectory of women’s healthcare research and radically accelerate the next generation of discoveries. A total of $100 million is available through the effort.

    Read more
  • New Mammography Quality Measures Available for Beta Testing

    The Centers for Medicare and Medicaid Services (CMS) Measures Management System posted a public comment period, open through Feb. 26, for four new breast cancer-related measures developed by Acumen, LLC.

    Read more